NCT04028167View on ClinicalTrials.gov

Induction FLOT With CROSS CRT for Esophageal Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 8, 2020

Primary Completion Date

April 19, 2026

Study Completion Date

April 19, 2027

Conditions
Adenocarcinoma EsophagusAdenocarcinoma of the Gastroesophageal Junction
Interventions
DRUG

Sequential FLOT followed by chemoradiation

Chemotherapy with Docetaxel, Oxaliplatin, and 5-Fluorouracil/ Leucovorin

Trial Locations (7)

80045

RECRUITING

University of Colorado Hospital, Aurora

80524

RECRUITING

UCHealth Northern Colorado - Poudre Valley Hospital, Fort Collins

80528

RECRUITING

UCHealth Northern Colorado - Harmony Campus, Fort Collins

80538

RECRUITING

UCHealth Northern Colorado Medical Center of the Rockies, Loveland

80634

RECRUITING

UCHealth Northern Colorado - Greeley Hospital, Greeley

80909

RECRUITING

UCHealth Southern Colorado - Memorial Hospital Central, Colorado Springs

80920

RECRUITING

UCHealth Southern Colorado - Memorial Hospital North, Colorado Springs

All Listed Sponsors
collaborator

American Cancer Society, Inc.

OTHER

collaborator

Cancer League of Colorado

OTHER

collaborator

National Cancer Institute (NCI)

NIH

lead

University of Colorado, Denver

OTHER